Zymergen

Zymergen, a biotechnology company focused on bio-manufacturing, laid off approximately 120 employees, representing about 25% of its workforce, in a restructuring effort announced in August 2022. The move was part of a strategic shift to prioritize near-term revenue opportunities and reduce operational costs, following challenges in commercializing its initial products. This reduction impacted teams across the organization as the company aimed to extend its financial runway and refocus its research and development efforts.

Zymergen laid off 80 employees on 2022-07-25.

Zymergen laid off 120 employees on 2021-09-23.